S&P Global places Biocon Biologics on positive CreditWatch on account of accelerated debt reduction
Written By : Ruchika Sharma
Published On 2025-12-11 10:00 GMT | Update On 2025-12-11 10:00 GMT
Advertisement
Bengaluru: Biocon Biologics Limited, a fully integrated, global biosimilars company and subsidiary of Biocon Ltd. has announced that S&P Global Ratings has recognized the Company’s accelerated progress in debt reduction by assigning a Positive outlook to its credit rating.
On Dec. 10, 2025, S&P Global Ratings placed its ‘BB’ long-term issuer credit rating on Biocon Biologics and the ‘BB’ issue rating on the senior secured notes issued by the Company with a Positive outlook, underscoring S&P’s view that these developments are a positive step toward retiring debt.
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a unique, fully integrated, global biosimilars company. The Company is leveraging cutting-edge science, tech platforms, global scale manufacturing capabilities and world-class quality systems.
Biocon Biologics has commercialized 10 biosimilars from its portfolio which are addressing the patients’ needs in key emerging markets and advanced markets like U.S., Europe, Australia, Canada, and Japan. It has a pipeline of 20+ biosimilar assets across diabetology, oncology, immunology, ophthalmology, bone health and other non- communicable diseases.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.